TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals, Inc.

TCON
TRACON Pharmaceuticals, Inc.US flagOther OTC
0.03
USD
- -
- -
109,725.00Market Cap

TRACON Pharmaceuticals, Inc. (TCON) Stock Split History

Learn about TRACON Pharmaceuticals, Inc.'s most recent 1-for-20 basis stock split on April 10, 2024. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about TRACON Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2024-04-10
Split Ratio: 1:20
Price Before Split: $0.15
Price After Split: $0.01

Developer API

Get TCON split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/TCON

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 20.00 times fewer shares (a 1:20 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of TRACON Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-04-101:20Yes$0.15$0.01
2019-11-081:10Yes$0.38$0.04

About TRACON Pharmaceuticals, Inc.

Company overview and industry information

TRACON Pharmaceuticals, Inc. (TCON) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to TRACON Pharmaceuticals, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.